Bifurcations: A Long Return Journey

When it looked like the simplest techniques reach the best outcomes, along came the DK Crush studies. Indeed, after the COVIS III results in bifurcations, it appeared we had started to retrace our steps back to the foundation. 

DKCRUSH-V: El tronco de la coronaria izquierda no es una bifurcación más

The purpose of this study was to compare long term outcomes of the remarkably simple 1-stent strategy to the main vessel (MV) with simple crossover alone vs. an additional side branch (SB) opening procedure with a second guidewire finalized with a kissing balloon.

Patients undergoing coronary PCI to a bifurcation (including left main) with the single stent strategy were included in this registry. 

2,194 patients were divided into the simple crossover–alone group (n=1.685, 76.8%) and the SB-opening group (n=509, 23.2%). Target lesion failure rate (a composite of cardiac death, target vessel myocardial infarction, and target lesion repeat revascularization) was assessed at a 5-year followup. 

The angiographic characteristics of patients in the SB-opening group with kissing balloon were more severe, even though lumen diameter resulted larger in this group. 

After 5 years, target lesion failure rate was similar between groups (7% vs 6.7%; p=0.947). 


Read also: A Headache for Cardiologists: Ischemia with Non-Obstructive Disease.


This was also true for the subgroup with left main lesion (9.5% vs. 11.3%; p=0.442) and lesions classified as Medina 1.1.1, 1.0.1 and 0.1.1 (5.3% vs. 7.8%; p=0.362). The latter are normally called true bifurcations. 

Conclusion

The remarkably simple 1-stent strategy to the main vessel with simple crossover alone showed long term comparable results to those obtained with an additional side branch opening procedure with a second guidewire finalized with a kissing balloon. 

j-jacasi-2021-04-002

Original title: 5-Year Outcome of Simple Crossover Stenting in Coronary Bifurcation Lesions Compared With Side Branch Opening. COBIS III 

Reference: Cheol Hyun Lee et al. JACC: Asia 2021;1:53–64.https://doi.org/10.1016/j.jacasi.2021.04.002


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....